New blood test could detect ovarian cancer early, improve treatment

High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. It is also the most lethal form, in part because clinicians do not have effective ways to screen women for it during the cancer's early stages, when it's easiest to treat.

Related Keywords

Monica Neuman ,Lily Ramsey ,X Mona Guo ,Varun Khetan ,Monique Spillman ,Lynda Diane Roman ,Heather Miller ,Gerald Gooden ,David Buckley ,Bodour Salhia ,Juan Pablo Lewinger ,Lee Shulman ,Advisor Of Cpg Diagnostics Inc ,Epigenomic Regulation Research Program ,University Of Arkansas ,Rockefeller Cancer Institute ,Cpg Diagnostics Inc ,Wright Foundation ,Department Of Population ,Public Health Sciences ,Feinberg School Of Medicine ,Division Of Gynecologic Oncology ,Keck School Of Medicine ,Norris Comprehensive Cancer Center ,Northwestern University ,Department Of Translational Genomics ,Clinical Cancer Research ,Comprehensive Cancer Center ,Keck School ,Ben Yi Tew ,Translational Genomics ,Gynecologic Oncology ,Feinberg School ,Chief Medical Advisor ,Cpg Diagnostics ,Swing Against Cancer ,Comprehensive Cancer ,Blood ,Blood Test ,Dancer ,Ovarian Cancer ,Biopsy ,Biotechnology ,Arcinoma ,Fell ,Pg ,Iagnostic ,Iagnostics ,Na ,Na Methylation ,Enomic ,Genomics ,Medicine ,Ncology ,Reclinical ,Research ,Surgery ,